Differential expression of PMCA2 mRNA isoforms in a cohort of Spanish patients with breast tumor types
Open Access
- 2 October 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (6) , 6950-6959
Abstract
The present study examined the mRNA expression levels of different isoforms of the plasma membrane calcium ATPase 2 (PMCA2) gene generated by alternative splicing at the first intracellular loop (site A) and C‑terminal region (site C) in 85 human breast cancer tumor and 69 adjacent non‑tumor tissues. Associations were identified between the expression of PMCA2 splice isoforms and the following clinical variables: Estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status, tumor size, staging and histological classification, and lymph node status. Transcripts including splice site A or splice site C were amplified by reverse transcription‑quantitative polymerase chain reaction using PMCA2 isoform‑specific primers. Tumor and adjacent tissues were determined to express the different PMCA2 splice isoforms 2w, 2x and 2z (site A), and 2b (site C). The mRNA levels for these variants indicated high biological variability, but increased expression was observed in breast tumor tissues, compared with in adjacent tissues. Significantly increased PMCA2x/b expression levels were detected in breast tumor tissues histologically classified as lobulillar, compared with in ductal‑types breast tumor tissues (P<0.028). Furthermore, PMCA2z expression was significantly associated with PR status (P<0.024, compared with in PR‑negative tumor tissues), and PMCA2w expression was significantly associated with ER status (P<0.048, increased in ER‑positive tumor tissues, compared with ER‑negative tumor tissues). Finally, PMCA2b was overexpressed in HER2‑positive tumor tissues, compared with in HER2‑negative tumor tissues (P<0.014). The data demonstrated the differential mRNA expression of a number of splice site A and C variants of PMCA2 in breast tumor and adjacent tissues, depending on tumor hormone receptor status and histological classification. In agreement with previous data, PMCA2b was overexpressed in HER2‑positive tumor tissues, indicating that high mRNA levels of this variant could be a marker of poor prognosis.Keywords
This publication has 44 references indexed in Scilit:
- Apical localization of PMCA2w/b is enhanced in terminally polarized MDCK cellsBiochemical and Biophysical Research Communications, 2011
- Apical Scaffolding Protein NHERF2 Modulates the Localization of Alternatively Spliced Plasma Membrane Ca2+ Pump 2B Variants in Polarized Epithelial CellsJournal of Biological Chemistry, 2010
- Deletions and Mutations in the Acidic Lipid-binding Region of the Plasma Membrane Ca2+ PumpJournal of Biological Chemistry, 2010
- PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancerProceedings of the National Academy of Sciences, 2010
- Plasma membrane calcium pumps and their emerging roles in cancerWorld Journal of Biological Chemistry, 2010
- Localization of plasma membrane and secretory calcium pumps in the mammary glandBiochemical and Biophysical Research Communications, 2008
- Plasma-membrane Ca2+ pumps: structural diversity as the basis for functional versatilityBiochemical Society Transactions, 2007
- Alternative splice variants of plasma membrane calcium-ATPases in human corneal epitheliumExperimental Eye Research, 2007
- Splice-Site A Choice Targets Plasma-Membrane Ca2+-ATPase Isoform 2 to Hair BundlesJournal of Neuroscience, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001